Biotech

All Articles

Analysts explore Avidity's DMD gain, exposing distinctions in records

.Avidity Biosciences impressed real estate investors along with phase 1/2 records in Duchenne muscle...

Actinogen's cortisol blocker stops working phase 2 depression research study

.Actinogen Medical's cortisol blocker has overlooked the key endpoint of a stage 2 research study in...

Bivictrix determines going exclusive only way to take ADC right into center

.Antibody-drug conjugates (ADCs) have actually gone to the facility of several a billion-dollar biob...

TPG leadings up funds to $580M for financial investments across life sciences

.Property manager TPG, which has sustained biotechs such as Sionna Therapeutics and Santa Clam Ana B...

Merck stops phase 3 TIGIT trial in lung cancer for impossibility

.Merck &amp Co.'s TIGIT system has gone through yet another trouble. Months after shuttering a perio...

After a tough year, Exscientia folds into Recursion

.After a year defined through pipe cuts, the departure of its own CEO and cutbacks, Exscientia will ...

Cullinan, after $25M offer, restore bispecific to Harbour

.Cullinan Therapy was actually impressed enough with Harbour BioMed's bispecific invulnerable reacto...

A nearer check out Fierce Biotech's Strong 15

.In this particular week's episode of "The Leading Pipe," our team are actually diving in to Strong ...

Lilly experiences phase 2 failure of tau-targeting med

.The confetti is still flying from Eli Lilly's gathering commemorating the approval of Alzheimer's h...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...